Table 3

Baseline date of two groups
Variables CHM (n = 106) placebo (n = 54) P Values
Characteristic P > 0.05
 Age(year) 39.48 ±13.75 41.63 ± 12.31
 Sex ratio(male:female) 35:71 15:39
 Height(Cm) 164.94 ± 7.41 164.57 ± 7.01
 Weight(Kg) 58.25 ± 10.04 58.91 ± 9.85
 Course of disease(month) 43.24 ± 51.41 45.30 ± 65.42
TDS and SDS scores (week 0)
 Gastroenterologist TDS scores 6.58 ± 2.23 6.61 ± 2.11
 Patient TDS scores 6.56 ± 2.18 6.81 ± 2.31
 Gastroenterologist SDS scores
  Epigastric pain 3.32 ± 2.27 2.85 ± 2.10
  Epigastric burning 0.98 ± 1.74 0.96 ± 1.67
  Postprandial fullness and bloating 5.04 ± 1.97 5.25 ± 1.96
  Early satiety 3.35 ± 2.39 3.69 ± 2.33
 Patient SDS scores
  Epigastric pain 3.25 ± 2.28 2.96 ± 2.27
  Epigastric burning 1.00 ± 1.76 1.02 ± 1.79
  Postprandial fullness and bloating 5.02 ± 1.93 5.19 ± 1.94
  Early satiety 3.33 ± 2.37 3.76 ± 2.44

Zhang et al.

Zhang et al. BMC Complementary and Alternative Medicine 2013 13:54   doi:10.1186/1472-6882-13-54

Open Data